Drug maker Johnson & Johnson has agreed to pay $2.2 billion in - TopicsExpress



          

Drug maker Johnson & Johnson has agreed to pay $2.2 billion in civil and criminal fines to settle claims it improperly marketed the antipsychotic medication Risperdal to children, seniors and people with developmental disabilities. RLG, which represents clients in Risperdal lawsuits, notes that the federal government has reported that there are health risks associated with use of the drug among those groups. rotlaw/updates/risperdal-lawsuit-news-rottenstein-law-group-llp-comments-2-billion-risperdal-settlement-report/
Posted on: Mon, 11 Nov 2013 17:46:01 +0000

Trending Topics



Recently Viewed Topics




© 2015